199
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: Effect of different processing and analysis approaches on sample sizes

, , , , , , , , , , , , , , & show all
Pages 109-113 | Published online: 12 Sep 2011

References

  • ACR. 2000. Phantom test guidance for the ACR MRI accredition program. Reston V, American College of Radiology.
  • Ashburner J. 2007. A fast diffeomorphic image registration algorithm. Neuroimage 38:95–113.
  • Ashburner J, Friston KJ. 2005. Unified segmentation. Neuroimage 26:839–851.
  • Brown H, Prescott R. 1999. Applied mixed models in medicine. Chichester, UK: John Wiley & Sons Ltd.
  • Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, NY: Erlbaum.
  • Coupe P, Yger P, Prima S, Hellier P, Kervrann C, Barillot C. 2008. An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images. IEEE Trans Med Imaging 27:425–441.
  • Evans MC, Barnes J, Nielsen C, Kim LG, Clegg SL, Blair M, . 2009. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. Eur Radiol 20: 674–682.
  • Ewers M, Teipel SJ, Dietrich O, Schonberg SO, Jessen F, Heun R, . 2006. Multicenter assessment of reliability of cranial MRI. Neurobiol Aging 27:1051–1059.
  • Folstein MF, Folstein SE, McHugh PR. 1975. Mini-mental-state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198.
  • Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN. 2000. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 57:339–344.
  • Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, . 2005. Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64:1563–1572.
  • Gauthier S, Aisen PS, Ferris SH, Saumier D, Duong A, Haine D, . 2009. Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study. J Nutr Health Aging 13:550–557.
  • Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, . 2010. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9:560–574.
  • Johnson DK, Barrow W, Anderson R, Harsha A, Honea R, Brooks WM, . 2010. Diagnostic utility of cerebral white matter integrity in early Alzheimer's disease. Int J Neurosci 120:544–550.
  • Kornhuber J, Schmidtke K, Frolich L, Perneczky R, Wolf S, Hampel H, . 2009. Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord 27:404–417.
  • Lee H, Prohovnik I. 2008. Cross-validation of brain segmentation by SPM5 and SIENAX. Psychiatry Res 164:172–177.
  • Littell RC, Milliken GA, Stroup WW, Wolfinger RD. 1996. SAS System for Mixed Models. Cary, NC: SAS Institute Inc.
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939–944.
  • Moretti B, Fadili LM, Ruan S, Bloyet N, Mazoyer B. 2000. Phantom-based performance evaluation: application to brain segmentation from magnetic resonance images. Med Image Anal 4:303–316.
  • Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, . 2010. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. J Am Med Assoc 304:1903–1911.
  • Rajapakse JC, Giedd JN, Rapoport JL. 1997. Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans Med Imaging 16:176–186.
  • Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC. 2010. Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging 31:1452–62, 1462 e1–2.
  • Teipel SJ, Mitchell A, Möller H-J, Hampel H. 2007. Improving linear modeling of cognitive decline in patients with mild cognitive impairment: Comparison of two methods. J Neural Transm Suppl 72:241–247.
  • Teipel SJ, Ewers M, Wolf S, Jessen F, Kolsch H, Arlt S, . 2010. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res 182:244–250.
  • Tohka J, Zijdenbos A, Evans A. 2004. Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage 23:84–97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.